Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 66 | 2024 | 4235 | 8.790 |
Why?
|
Graft Rejection | 53 | 2024 | 4446 | 6.370 |
Why?
|
Organ Transplantation | 15 | 2024 | 1157 | 3.400 |
Why?
|
Graft Survival | 25 | 2024 | 3820 | 2.980 |
Why?
|
Facial Transplantation | 10 | 2023 | 221 | 2.970 |
Why?
|
Immunosuppressive Agents | 27 | 2024 | 4176 | 2.540 |
Why?
|
T-Lymphocytes, Regulatory | 21 | 2024 | 3080 | 2.350 |
Why?
|
Kidney Failure, Chronic | 18 | 2024 | 2472 | 2.340 |
Why?
|
Transplantation | 4 | 2024 | 219 | 1.850 |
Why?
|
Glomerulonephritis, Membranous | 2 | 2024 | 88 | 1.460 |
Why?
|
Interleukin-2 | 4 | 2024 | 1889 | 1.310 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2019 | 138 | 1.260 |
Why?
|
Isoantibodies | 6 | 2023 | 674 | 1.240 |
Why?
|
Heart Transplantation | 12 | 2021 | 3233 | 1.140 |
Why?
|
T-Lymphocytes | 15 | 2023 | 10194 | 1.130 |
Why?
|
Immunity, Humoral | 3 | 2022 | 606 | 1.120 |
Why?
|
Transplantation, Homologous | 14 | 2024 | 4807 | 1.090 |
Why?
|
Skin Transplantation | 4 | 2022 | 1083 | 1.040 |
Why?
|
Nephrotic Syndrome | 4 | 2024 | 390 | 1.020 |
Why?
|
Receptors, Notch | 3 | 2020 | 743 | 0.950 |
Why?
|
Living Donors | 4 | 2021 | 641 | 0.910 |
Why?
|
Tissue Donors | 5 | 2022 | 2332 | 0.890 |
Why?
|
Desensitization, Immunologic | 2 | 2022 | 556 | 0.870 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2018 | 1784 | 0.860 |
Why?
|
Recurrence | 9 | 2024 | 8466 | 0.850 |
Why?
|
Transplantation Immunology | 2 | 2016 | 532 | 0.850 |
Why?
|
Glomerulonephritis | 3 | 2021 | 331 | 0.790 |
Why?
|
Kidney Diseases | 6 | 2024 | 2091 | 0.780 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2022 | 664 | 0.780 |
Why?
|
Postoperative Complications | 13 | 2024 | 15633 | 0.750 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 63 | 0.740 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2024 | 335 | 0.720 |
Why?
|
Proteinuria | 1 | 2023 | 607 | 0.710 |
Why?
|
Immune Tolerance | 7 | 2020 | 2302 | 0.700 |
Why?
|
Expert Testimony | 1 | 2022 | 364 | 0.670 |
Why?
|
Th1 Cells | 4 | 2016 | 1036 | 0.670 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2019 | 169 | 0.660 |
Why?
|
Antilymphocyte Serum | 3 | 2022 | 487 | 0.630 |
Why?
|
Immunity, Innate | 3 | 2023 | 3066 | 0.630 |
Why?
|
Brain Death | 1 | 2022 | 357 | 0.620 |
Why?
|
Diet, Gluten-Free | 1 | 2021 | 283 | 0.620 |
Why?
|
Aptamers, Nucleotide | 1 | 2019 | 165 | 0.610 |
Why?
|
Chemokines | 1 | 2022 | 959 | 0.590 |
Why?
|
Dairy Products | 1 | 2021 | 490 | 0.590 |
Why?
|
Kidney Tubules, Proximal | 1 | 2019 | 383 | 0.580 |
Why?
|
Humans | 125 | 2024 | 761572 | 0.580 |
Why?
|
Immunity, Cellular | 3 | 2022 | 1560 | 0.580 |
Why?
|
Antibodies | 3 | 2022 | 2418 | 0.570 |
Why?
|
Antibodies, Monoclonal | 6 | 2023 | 9177 | 0.570 |
Why?
|
Bone Diseases | 1 | 2021 | 418 | 0.570 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1924 | 0.560 |
Why?
|
Antigens, CD20 | 2 | 2021 | 200 | 0.550 |
Why?
|
Adaptive Immunity | 2 | 2024 | 726 | 0.540 |
Why?
|
Podocytes | 2 | 2021 | 405 | 0.540 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 496 | 0.530 |
Why?
|
Cyclosporine | 2 | 2016 | 778 | 0.530 |
Why?
|
Antigen Presentation | 2 | 2021 | 1251 | 0.520 |
Why?
|
Immunocompromised Host | 5 | 2021 | 857 | 0.520 |
Why?
|
Plasmapheresis | 4 | 2022 | 206 | 0.510 |
Why?
|
Lymphocyte Depletion | 2 | 2021 | 602 | 0.510 |
Why?
|
T-Lymphocyte Subsets | 4 | 2021 | 1802 | 0.470 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.470 |
Why?
|
Transplantation, Heterologous | 4 | 2024 | 2385 | 0.470 |
Why?
|
Blood Proteins | 1 | 2019 | 1173 | 0.460 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4758 | 0.460 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1779 | 0.460 |
Why?
|
Kidney | 14 | 2024 | 7047 | 0.450 |
Why?
|
Mice, Inbred BALB C | 10 | 2020 | 6214 | 0.440 |
Why?
|
Lymphocyte Activation | 7 | 2016 | 5485 | 0.440 |
Why?
|
Interleukin-17 | 3 | 2020 | 912 | 0.430 |
Why?
|
Donor Selection | 1 | 2015 | 232 | 0.430 |
Why?
|
Histocompatibility | 1 | 2014 | 317 | 0.430 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2014 | 1351 | 0.430 |
Why?
|
Apolipoproteins | 1 | 2015 | 326 | 0.420 |
Why?
|
Access to Information | 1 | 2016 | 316 | 0.420 |
Why?
|
Internationality | 1 | 2018 | 1001 | 0.420 |
Why?
|
Computer-Assisted Instruction | 1 | 2016 | 362 | 0.420 |
Why?
|
Immunomodulation | 1 | 2016 | 549 | 0.420 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 293 | 0.410 |
Why?
|
Animals | 41 | 2024 | 168467 | 0.410 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3086 | 0.410 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3206 | 0.410 |
Why?
|
Signal Transduction | 12 | 2020 | 23447 | 0.400 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 449 | 0.400 |
Why?
|
Pandemics | 8 | 2020 | 8656 | 0.380 |
Why?
|
HLA Antigens | 3 | 2022 | 1328 | 0.380 |
Why?
|
Tissue and Organ Harvesting | 1 | 2014 | 373 | 0.370 |
Why?
|
Tissue and Organ Procurement | 1 | 2019 | 962 | 0.370 |
Why?
|
Complement System Proteins | 1 | 2014 | 735 | 0.370 |
Why?
|
Membrane Proteins | 5 | 2021 | 7858 | 0.370 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 461 | 0.360 |
Why?
|
Renal Insufficiency | 2 | 2020 | 809 | 0.360 |
Why?
|
Autoimmunity | 2 | 2019 | 1356 | 0.360 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 676 | 0.360 |
Why?
|
Immunophenotyping | 2 | 2017 | 1869 | 0.360 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3156 | 0.360 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2022 | 2243 | 0.350 |
Why?
|
Drug Resistance | 1 | 2016 | 1596 | 0.350 |
Why?
|
Hypophosphatemia | 1 | 2011 | 92 | 0.350 |
Why?
|
Withholding Treatment | 1 | 2014 | 617 | 0.340 |
Why?
|
Proteome | 1 | 2019 | 1862 | 0.330 |
Why?
|
Europe | 3 | 2021 | 3422 | 0.330 |
Why?
|
Steroids | 1 | 2014 | 929 | 0.330 |
Why?
|
Th2 Cells | 3 | 2013 | 1060 | 0.320 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 1032 | 0.320 |
Why?
|
Interferon-gamma | 2 | 2023 | 3162 | 0.320 |
Why?
|
Mice, Inbred C57BL | 15 | 2020 | 22172 | 0.310 |
Why?
|
Fractures, Bone | 1 | 2021 | 2046 | 0.310 |
Why?
|
Immunoconjugates | 3 | 2013 | 953 | 0.310 |
Why?
|
Th17 Cells | 4 | 2021 | 794 | 0.310 |
Why?
|
Mice | 25 | 2024 | 81533 | 0.310 |
Why?
|
Opportunistic Infections | 3 | 2020 | 376 | 0.310 |
Why?
|
Kidney Function Tests | 2 | 2024 | 679 | 0.300 |
Why?
|
Antibody Formation | 2 | 2023 | 1395 | 0.300 |
Why?
|
Neoplasms | 5 | 2022 | 22173 | 0.300 |
Why?
|
Transplantation Tolerance | 2 | 2022 | 605 | 0.300 |
Why?
|
Male | 47 | 2024 | 360842 | 0.290 |
Why?
|
Phosphates | 1 | 2011 | 770 | 0.280 |
Why?
|
Antibodies, Blocking | 3 | 2019 | 243 | 0.280 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2012 | 499 | 0.280 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2188 | 0.280 |
Why?
|
Thymus Gland | 1 | 2012 | 1243 | 0.280 |
Why?
|
Proteomics | 2 | 2019 | 3848 | 0.270 |
Why?
|
Granzymes | 3 | 2022 | 277 | 0.270 |
Why?
|
Retrospective Studies | 16 | 2024 | 80646 | 0.270 |
Why?
|
Brazil | 2 | 2021 | 1230 | 0.270 |
Why?
|
Glomerular Filtration Rate | 5 | 2024 | 2177 | 0.270 |
Why?
|
Learning | 1 | 2016 | 1740 | 0.270 |
Why?
|
Interleukin-6 | 2 | 2013 | 3208 | 0.260 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1935 | 0.260 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2022 | 974 | 0.260 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4369 | 0.250 |
Why?
|
Biopsy | 6 | 2023 | 6766 | 0.250 |
Why?
|
Autoimmune Diseases | 2 | 2017 | 2244 | 0.250 |
Why?
|
Female | 43 | 2024 | 392686 | 0.250 |
Why?
|
Creatinine | 3 | 2019 | 1899 | 0.250 |
Why?
|
Middle Aged | 28 | 2024 | 220920 | 0.250 |
Why?
|
Swine | 4 | 2024 | 5915 | 0.250 |
Why?
|
Inflammation | 5 | 2023 | 10773 | 0.240 |
Why?
|
Dyslipidemias | 1 | 2012 | 868 | 0.240 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2011 | 2872 | 0.230 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2024 | 40 | 0.230 |
Why?
|
Education, Medical | 1 | 2016 | 1725 | 0.230 |
Why?
|
Down-Regulation | 1 | 2011 | 2919 | 0.230 |
Why?
|
Lymphoproliferative Disorders | 2 | 2021 | 531 | 0.230 |
Why?
|
Skin | 4 | 2022 | 4484 | 0.220 |
Why?
|
Placenta | 1 | 2013 | 1709 | 0.220 |
Why?
|
Antiviral Agents | 1 | 2016 | 3060 | 0.220 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2024 | 106 | 0.220 |
Why?
|
Internet | 1 | 2016 | 3093 | 0.220 |
Why?
|
Receptors, Phospholipase A2 | 2 | 2021 | 33 | 0.220 |
Why?
|
Membrane Glycoproteins | 2 | 2011 | 3701 | 0.220 |
Why?
|
Pilot Projects | 4 | 2023 | 8633 | 0.210 |
Why?
|
Cell Differentiation | 5 | 2024 | 11530 | 0.210 |
Why?
|
Calcium | 1 | 2016 | 5722 | 0.210 |
Why?
|
Ligands | 5 | 2022 | 3272 | 0.210 |
Why?
|
Time Factors | 9 | 2021 | 39970 | 0.210 |
Why?
|
Galactosyltransferases | 1 | 2024 | 276 | 0.210 |
Why?
|
Colchicine | 2 | 2021 | 259 | 0.210 |
Why?
|
Peptides | 2 | 2011 | 4358 | 0.200 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 123 | 0.190 |
Why?
|
Cytokines | 5 | 2021 | 7396 | 0.190 |
Why?
|
Nephrosis, Lipoid | 1 | 2021 | 45 | 0.190 |
Why?
|
Risk Factors | 12 | 2024 | 74213 | 0.190 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39107 | 0.190 |
Why?
|
Prognosis | 6 | 2024 | 29629 | 0.190 |
Why?
|
Mycophenolic Acid | 3 | 2024 | 349 | 0.190 |
Why?
|
Chemokines, CC | 1 | 2022 | 283 | 0.180 |
Why?
|
Animals, Genetically Modified | 2 | 2024 | 1561 | 0.180 |
Why?
|
Organ Preservation | 1 | 2024 | 382 | 0.180 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3615 | 0.180 |
Why?
|
Adult | 21 | 2024 | 221203 | 0.180 |
Why?
|
Bone Marrow | 1 | 2011 | 2911 | 0.180 |
Why?
|
Prospective Studies | 8 | 2023 | 54426 | 0.180 |
Why?
|
Treatment Outcome | 13 | 2024 | 64684 | 0.180 |
Why?
|
B-Lymphocyte Subsets | 1 | 2021 | 239 | 0.170 |
Why?
|
Nephritis, Interstitial | 1 | 2021 | 155 | 0.170 |
Why?
|
Glycolysis | 1 | 2024 | 835 | 0.170 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13642 | 0.170 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2019 | 71 | 0.170 |
Why?
|
Minerals | 1 | 2021 | 283 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 616 | 0.160 |
Why?
|
Germinal Center | 1 | 2022 | 380 | 0.160 |
Why?
|
Acute Disease | 4 | 2018 | 7237 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2020 | 4580 | 0.160 |
Why?
|
Mice, Knockout | 7 | 2013 | 14416 | 0.160 |
Why?
|
Hyperparathyroidism | 1 | 2020 | 337 | 0.160 |
Why?
|
Patient Selection | 2 | 2022 | 4244 | 0.160 |
Why?
|
Incidence | 6 | 2024 | 21355 | 0.160 |
Why?
|
Skin Pigmentation | 1 | 2021 | 277 | 0.160 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4431 | 0.160 |
Why?
|
Crystallization | 1 | 2019 | 534 | 0.160 |
Why?
|
Hyperammonemia | 1 | 2019 | 76 | 0.160 |
Why?
|
Hypokalemia | 1 | 2019 | 153 | 0.160 |
Why?
|
STAT5 Transcription Factor | 1 | 2019 | 265 | 0.160 |
Why?
|
Peri-Implantitis | 1 | 2020 | 116 | 0.150 |
Why?
|
Retreatment | 1 | 2020 | 598 | 0.150 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 95 | 0.150 |
Why?
|
Quality of Life | 2 | 2021 | 13367 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6312 | 0.150 |
Why?
|
Remission Induction | 2 | 2024 | 2397 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2022 | 2547 | 0.150 |
Why?
|
Transplants | 1 | 2020 | 206 | 0.150 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 695 | 0.150 |
Why?
|
Survival Analysis | 2 | 2021 | 10090 | 0.150 |
Why?
|
Cyclophosphamide | 2 | 2021 | 2220 | 0.140 |
Why?
|
Nephrology | 1 | 2021 | 263 | 0.140 |
Why?
|
Paraproteinemias | 1 | 2019 | 248 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 328 | 0.140 |
Why?
|
Plasma Cells | 1 | 2020 | 599 | 0.140 |
Why?
|
Aged | 16 | 2022 | 169310 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4026 | 0.140 |
Why?
|
North America | 1 | 2020 | 1276 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9420 | 0.140 |
Why?
|
Blogging | 1 | 2016 | 15 | 0.130 |
Why?
|
Up-Regulation | 2 | 2018 | 4124 | 0.130 |
Why?
|
Risk Assessment | 7 | 2024 | 23996 | 0.130 |
Why?
|
Autoantibodies | 2 | 2021 | 2116 | 0.130 |
Why?
|
Antigens, CD | 3 | 2018 | 4001 | 0.130 |
Why?
|
Replantation | 1 | 2017 | 145 | 0.130 |
Why?
|
Reperfusion | 1 | 2017 | 271 | 0.130 |
Why?
|
Serpins | 2 | 2017 | 247 | 0.130 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18253 | 0.130 |
Why?
|
Amputation, Traumatic | 1 | 2017 | 135 | 0.130 |
Why?
|
Albuminuria | 1 | 2019 | 657 | 0.130 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9541 | 0.130 |
Why?
|
Point-of-Care Systems | 1 | 2024 | 1213 | 0.130 |
Why?
|
Tacrolimus | 2 | 2020 | 733 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 2 | 2024 | 1881 | 0.120 |
Why?
|
Death | 1 | 2019 | 676 | 0.120 |
Why?
|
Chronic Disease | 4 | 2018 | 9319 | 0.120 |
Why?
|
Renal Replacement Therapy | 1 | 2017 | 282 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 3 | 2016 | 1844 | 0.120 |
Why?
|
Flow Cytometry | 4 | 2013 | 5869 | 0.120 |
Why?
|
Hypoparathyroidism | 1 | 2015 | 136 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2013 | 57 | 0.110 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 434 | 0.110 |
Why?
|
Dysuria | 1 | 2013 | 6 | 0.110 |
Why?
|
Litter Size | 1 | 2013 | 49 | 0.110 |
Why?
|
Parathyroidectomy | 1 | 2015 | 242 | 0.110 |
Why?
|
Teriparatide | 1 | 2015 | 227 | 0.110 |
Why?
|
Adoptive Transfer | 2 | 2013 | 819 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1943 | 0.110 |
Why?
|
Embryo Loss | 1 | 2013 | 55 | 0.110 |
Why?
|
Cells, Cultured | 4 | 2019 | 18965 | 0.110 |
Why?
|
Face | 1 | 2019 | 1026 | 0.110 |
Why?
|
Complement Inactivating Agents | 2 | 2024 | 53 | 0.110 |
Why?
|
Exosomes | 1 | 2017 | 424 | 0.110 |
Why?
|
Models, Immunological | 2 | 2013 | 513 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5821 | 0.100 |
Why?
|
Homeostasis | 2 | 2014 | 3323 | 0.100 |
Why?
|
Mice, Inbred CBA | 1 | 2013 | 436 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2021 | 2057 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1886 | 0.100 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 117 | 0.100 |
Why?
|
Dexamethasone | 1 | 2019 | 1948 | 0.100 |
Why?
|
Intestines | 1 | 2021 | 1909 | 0.100 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1435 | 0.100 |
Why?
|
Histocompatibility, Maternal-Fetal | 1 | 2011 | 9 | 0.100 |
Why?
|
Histocompatibility Antigens | 1 | 2013 | 464 | 0.100 |
Why?
|
United States | 6 | 2024 | 72335 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3579 | 0.100 |
Why?
|
Hypothermia, Induced | 1 | 2017 | 753 | 0.100 |
Why?
|
Extremities | 1 | 2017 | 867 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2018 | 2707 | 0.100 |
Why?
|
Immunologic Factors | 2 | 2021 | 1589 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1626 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2017 | 650 | 0.090 |
Why?
|
Calcium Compounds | 1 | 2011 | 38 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8002 | 0.090 |
Why?
|
Immunoenzyme Techniques | 2 | 2011 | 1705 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.090 |
Why?
|
Complement C3 | 2 | 2024 | 435 | 0.090 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 371 | 0.090 |
Why?
|
Self Tolerance | 1 | 2011 | 123 | 0.090 |
Why?
|
Immunologic Memory | 2 | 2016 | 1359 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1860 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1321 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.090 |
Why?
|
Cause of Death | 2 | 2018 | 3683 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2018 | 2747 | 0.090 |
Why?
|
Apoptosis | 3 | 2022 | 9489 | 0.090 |
Why?
|
Growth Inhibitors | 1 | 2011 | 378 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1809 | 0.090 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1749 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3341 | 0.090 |
Why?
|
Survival Rate | 1 | 2024 | 12725 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.080 |
Why?
|
Acetates | 1 | 2011 | 321 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1135 | 0.080 |
Why?
|
Kidney Glomerulus | 1 | 2011 | 568 | 0.080 |
Why?
|
Comorbidity | 2 | 2020 | 10508 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1899 | 0.080 |
Why?
|
Young Adult | 6 | 2021 | 59255 | 0.080 |
Why?
|
Publishing | 1 | 2016 | 833 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1702 | 0.080 |
Why?
|
Ischemia | 1 | 2017 | 1883 | 0.080 |
Why?
|
Cell Polarity | 1 | 2011 | 636 | 0.080 |
Why?
|
Serine Endopeptidases | 1 | 2013 | 1023 | 0.080 |
Why?
|
Canada | 2 | 2023 | 2122 | 0.080 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 795 | 0.080 |
Why?
|
Rabbits | 1 | 2014 | 4772 | 0.070 |
Why?
|
Forecasting | 1 | 2017 | 2928 | 0.070 |
Why?
|
Bone Density | 1 | 2021 | 3551 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7391 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 609 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12975 | 0.070 |
Why?
|
Spleen | 1 | 2013 | 2295 | 0.070 |
Why?
|
Anti-Infective Agents | 1 | 2014 | 983 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2013 | 1787 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2468 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2220 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15843 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20099 | 0.070 |
Why?
|
Child, Preschool | 4 | 2021 | 42230 | 0.070 |
Why?
|
Genotype | 2 | 2024 | 12990 | 0.070 |
Why?
|
Prednisone | 2 | 2021 | 1563 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2014 | 875 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6534 | 0.060 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 822 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3627 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1618 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18398 | 0.060 |
Why?
|
Brain | 2 | 2022 | 27120 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1463 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3808 | 0.060 |
Why?
|
Boston | 2 | 2014 | 9326 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.060 |
Why?
|
Complement C4b | 1 | 2023 | 126 | 0.050 |
Why?
|
Child | 5 | 2024 | 80156 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 88324 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11076 | 0.050 |
Why?
|
Administration, Oral | 1 | 2011 | 4021 | 0.050 |
Why?
|
Focal Adhesions | 1 | 2023 | 115 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8224 | 0.050 |
Why?
|
HLA-A2 Antigen | 1 | 2022 | 211 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8528 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9610 | 0.050 |
Why?
|
Models, Animal | 2 | 2024 | 2112 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2811 | 0.050 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2022 | 100 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2013 | 3466 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5492 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 802 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11904 | 0.050 |
Why?
|
Coronary Disease | 1 | 2015 | 5914 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2020 | 135 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6567 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2022 | 691 | 0.040 |
Why?
|
Azathioprine | 1 | 2021 | 354 | 0.040 |
Why?
|
Perfusion | 1 | 2024 | 1373 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 2021 | 562 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2021 | 778 | 0.040 |
Why?
|
Polyomavirus | 1 | 2020 | 234 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36192 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 17904 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2020 | 385 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1303 | 0.040 |
Why?
|
Vincristine | 1 | 2021 | 1036 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3397 | 0.040 |
Why?
|
Italy | 1 | 2020 | 842 | 0.040 |
Why?
|
Ritonavir | 1 | 2020 | 329 | 0.040 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 151 | 0.040 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 194 | 0.040 |
Why?
|
Erythema | 1 | 2019 | 262 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 2020 | 438 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3245 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58986 | 0.030 |
Why?
|
Heart Failure | 1 | 2021 | 11670 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2021 | 1796 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3415 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6403 | 0.030 |
Why?
|
Nephrectomy | 1 | 2021 | 937 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14032 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15266 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 743 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 379 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2020 | 756 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 823 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.030 |
Why?
|
Acute Coronary Syndrome | 1 | 2008 | 2190 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4352 | 0.030 |
Why?
|
Amyloidosis | 1 | 2021 | 817 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2021 | 612 | 0.030 |
Why?
|
Exanthema | 1 | 2019 | 503 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2192 | 0.030 |
Why?
|
Doxorubicin | 1 | 2021 | 2224 | 0.030 |
Why?
|
Immunotherapy | 2 | 2020 | 4652 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 871 | 0.030 |
Why?
|
Pregnancy | 2 | 2013 | 29876 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1422 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2048 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11461 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2020 | 1803 | 0.030 |
Why?
|
Cytomegalovirus Infections | 1 | 2020 | 831 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2202 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1175 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2865 | 0.030 |
Why?
|
Janus Kinases | 1 | 2013 | 248 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 377 | 0.030 |
Why?
|
Dental Implants | 1 | 2020 | 795 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3123 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2011 | 120 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1440 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2011 | 216 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4544 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 421 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6864 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2011 | 410 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 826 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 605 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3548 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2013 | 1202 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1157 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 909 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 891 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3537 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3905 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2012 | 1149 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41493 | 0.020 |
Why?
|
Capillaries | 1 | 2011 | 755 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2011 | 964 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2014 | 1141 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2986 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2297 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1971 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 1827 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1998 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1069 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 999 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2626 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12794 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4319 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5035 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2017 | 3744 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2015 | 4471 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5293 | 0.010 |
Why?
|
Aorta | 1 | 2010 | 2041 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5672 | 0.010 |
Why?
|
Lung Transplantation | 1 | 2010 | 1310 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 2008 | 973 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10721 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10448 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2898 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2013 | 3029 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11742 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16986 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9353 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12059 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13255 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14666 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23741 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7407 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20571 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26127 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15501 | 0.010 |
Why?
|